Arizona says it has run out of drugs for
executions
Send a link to a friend
[June 25, 2016]
By Ian Simpson
(Reuters) - Arizona has run out of
execution drugs, including a sedative implicated in botched lethal
injections, according to a filing on Friday in a court case challenging
the U.S. state's execution methods.
The Arizona Department of Corrections' supply of midazolam, a
sedative, expired on May 31 and it has not been able to replace it,
state lawyers said in the filing in Phoenix's U.S. District Court.
"What is more, the Department's source of midazolam has vanished
under pressure from death penalty opponents," the court document
said.
The lawsuit was filed on behalf of seven death-row inmates who
allege that Arizona's use of midazolam and two other drugs violate
the U.S. Constitution's ban on cruel and unusual punishment.
Since midazolam was at the heart of the lawsuit, the filing asked
the judge hearing the case, Neil Wake, to decide whether the suit
was moot.
The document said the Department of Corrections also lacked the
execution drugs pentobarbital and sodium thiopental.
Arizona has not carried out an execution since the July 2014
execution of Joseph Wood. He was administered 14 times the allowed
doses of midazolam and a narcotic, hydromorphone, and took almost
two hours to die.
Midazolam, a relative of Valium, has also been cited in a troubled
2014 execution in Oklahoma. It was at the center of a U.S. Supreme
Court decision last year where the court upheld its use in Oklahoma.
After the high court's ruling, Arizona switched to a three-step
protocol of midazolam, a paralytic drug and potassium chloride,
which stops the heart.
[to top of second column] |
The execution chamber at the Arizona State Prison Complex- Florence
- HU9 is shown in the screen grab from a video provided by the
Arizona Department of Corrections March 4, 2015. REUTERS/Arizona
Department of Corrections/Handout
The protocol was the same as that decided in the Supreme Court case,
and state lawyers have argued that midazolam thus was acceptable for
use in Arizona.
But Wake has ruled that Supreme Court decisions in the Oklahoma case
and another involving midazolam were based only on the facts
specific to them.
Drug company Pfizer Inc <PFE.N> said last month it had banned the
sale of execution drugs, including midazolam. The move cut off the
last major U.S. source for drugs in the deadly mixes.
The number of inmates executed in the United State has plummeted
since the 1990s, with 14 executions so far this year, according to
the Death Penalty Information Center.
(Reporting by Ian Simpson in Washington; Editing by Mary Milliken)
[© 2016 Thomson Reuters. All rights
reserved.]
Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|